Capsaicin From Chili Peppers Could Help Kill Cancer Cells

635775216345788099chilismixed.jpg

11 Sep 2015 --- Capsaicin, the compound responsible for chilies’ heat, is used in creams sold to relieve pain, and recent research shows that in high doses, it kills prostate cancer cells. Now researchers are finding clues that help explain how the substance works. Their conclusions suggest that one day it could come in a new, therapeutic form. Their study appears in ACS’ The Journal of Physical Chemistry B.

About 10 years ago, researchers reported that capsaicin can kill prostate cancer cells in mice while leaving healthy cells unharmed. But translating that dose to humans would require them to eat a huge number of chili peppers per day. Figuring out how capsaicin works could help researchers transform it into an effective drug in the form of an injection or pill. Until recently, scientists did not understand the mechanism by which capsaicin targeted cancer cells, but they have now figured out that the molecule binds to a cell’s surface and affects the membrane, which surrounds and protects the cell. That finding prompted Ashok Kumar Mishra and Jitendriya Swain to try to gain a deeper understanding of capsaicin’s effects so it might be harnessed in the future for new medicines.

The scientists were able to detect how the compound interacts with cell membranes by monitoring its natural fluorescence. The study showed that capsaicin lodges in the membranes near the surface. Add enough of it, and the capsaicin essentially causes the membranes to come apart. This means that the cancer cell is exposed and vulnerable to conventional and other treatments With additional research, this insight could help lead to novel tools against cancer or other conditions. It has previously been discovered that capsaicin induces cancer cell apoptosis via inhibition of mitochondrial respiration which the cells rely on to survive.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Packaging & Technology News

Ready meals with a pulse: Gaia Pulses on sustainability from the outside in

18 May 2018 --- Dining out, in is pegged at number seven in Innova Market Insights top ten 2018 trends, and in this suit, we have seen the face of ready meals drastically change from plastic packaged, typically calorie-laden curries and pizza. Delivering on this exciting front is London based Gaia Pulses; coined the UK’s first ready meal in GM-free compostable packaging. NutritionInsight spoke to Yolanda Antonopoulou, Founder, about the meals which are made for the mindful, on-the-go consumer.

Nutrition & Health News

Vitamin A may play vital role in preventing lethal liver cancer

24 Apr 2018 --- Acyclic retinoid, an artificial compound derived from vitamin A, may prevent the reoccurrence of liver cancer tumors. The vitamin A compound targets one common class of liver cancer cells, hepatocellular carcinoma (HCC), which are indicative of a highly lethal cancer with an extremely high rate of recurrence and relapse. The study proves how the acyclic retinoid can slow the growth of the cancer: by targeting levels of the dangerous MYCN in cells, this is true even amongst highly treatment-resilient “cancer stem cells.”

Nutrition & Health News

Gut-brain axis: NZMP SureStart joins research program to aid infant formula development

09 Apr 2018 --- NZMP SureStart, the global B2B pediatric ingredients brand of Fonterra, has joined Smarter Lives, a five-year research program that investigates how nutrition impacts the gut-brain axis. Smarter Lives is funded by New Zealand’s Ministry of Business, Innovation and Employment and led by New Zealand research institute, AgResearch. It will investigate how foods influence brain function via the sophisticated communication systems between the gut and the brain.

Business News

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 --- Novartis has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based Nasdaq-listed clinical-stage gene therapy company for US$8.7 billion in cash (US$218 per share). The transaction was unanimously approved by the Boards of both companies. The move comes just days after Novartis agreed to sell its stake in a consumer healthcare joint venture for $13 billion to GlaxoSmithKline.

Nutrition & Health News

Immunity booster: Ingredia launches new lactoferrin ingredient

06 Apr 2018 --- Ingredia is to launch Proferrin, a native lactoferrin derived from French cow’s milk. According to the company, its expertise in cutting-edge separation techniques allows it to ensure that Proferrin features the highest purity on the market, with more than 96 percent of lactoferrin on total proteins. Proferrin aims to help people reinforce their immune system, such as children, pregnant women, athletes and the aging population. 

More Articles
URL : http://www.nutritioninsight.com:80/news/capsaicin-from-chili-peppers-could-help-kill-cancer-cells.html